Patricia Drake
Corporate Officer/Principal bij TREVENA, INC.
Vermogen: 41 760 $ op 31-05-2024
Actieve functies van Patricia Drake
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 11-11-2021 | - |
Loopbaan van Patricia Drake
Eerdere bekende functies van Patricia Drake
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-06-2021 | 01-09-2021 |
| MSD Finland Oy | Algemeen Directeur | 01-01-2019 | 01-05-2021 |
Opleiding van Patricia Drake
| Wichita State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Finland | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MSD Finland Oy |
- Beurs
- Insiders
- Patricia Drake
- Ervaring
